DVN
35
14
HOG
40
-5
NWS
60
4
M
25
4
IRM
41
7
ROP
59
2
HPE
10
4
DUK
74
-3
MTB
59
3
CAH
51
4
EA
54
-5
JBHT
38
2
TDC
28
2
ABBV
64
-4
PPG
41
-2
NVDA
52
6
PLD
41
4
GLW
46
2
GOOG
55
5
ORCL
52
5
DVN
35
14
HOG
40
-5
NWS
60
4
M
25
4
IRM
41
7
ROP
59
2
HPE
10
4
DUK
74
-3
MTB
59
3
CAH
51
4
EA
54
-5
JBHT
38
2
TDC
28
2
ABBV
64
-4
PPG
41
-2
NVDA
52
6
PLD
41
4
GLW
46
2
GOOG
55
5
ORCL
52
5
Financhill
Back

Webster Financial Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
34

WBS
Webster Financial

Last Price:
$48.51
Seasonality Move:
3.13%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$98.39
Seasonality Move:
6.73%
Sell
34
Webster Financial (WBS) is a Sell

Is Webster Financial a Buy, Sell or Hold?

  • The current Webster Financial [WBS] share price is $49.69. The Score for WBS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • WBS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

WBS Stock Price Chart

What is Webster Financial's stock price today?

  • The Webster Financial share price today is $49.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and WBS is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

WBS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.19 Sell
Relative Strength Index (14 RSI): 31 Sell
Chaikin Money Flow: -11073 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.97 - 60.13) Sell
Bollinger Bands (100): (52.87 - 60.47) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

WBS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.2 Sell
20-day SMA: 55.58 Sell
50-day SMA: 56.87 Sell
200-day SMA: 50.75 Sell
8-day EMA: 51.83 Sell
20-day EMA: 54.49 Sell
50-day EMA: 56.13 Sell
200-day EMA: 52.62 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

Webster Financial Earnings Growth & WBS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.05 per share, an increase this year of $0.69 per share, and an increase next year of $0.81 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Webster Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):